TY - JOUR
T1 - Role of Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection in the Management of Barrett's Related Neoplasia
AU - Nieuwenhuis, Esther A.
AU - Pech, Oliver
AU - Bergman, Jacques J. G. H. M.
AU - Pouw, Roos E.
N1 - Funding Information: E.A. Nieuwenhuis; no disclosures. O. Pech; disclosures: speaker fees from Medtronic, Olympus, Fujifilm, Boston Scientific, Falk, AbbVie, Bristol Myers Squibb, and Creo Medical. J.J.G.H.M. Bergman; disclosures: financial support for research from Covidien / Medtronic , Olympus Endoscopy , Cook Medical , Boston scientific , Erbe Medical , C2Therapeutic , Ninepoint Medical . Consultancy: Boston Scientific, Cook Medical, Covidien/Medtronic. R.E. Pouw; no disclosures. Funding Information: E.A. Nieuwenhuis; no disclosures. O. Pech; disclosures: speaker fees from Medtronic, Olympus, Fujifilm, Boston Scientific, Falk, AbbVie, Bristol Myers Squibb, and Creo Medical. J.J.G.H.M. Bergman; disclosures: financial support for research from Covidien/Medtronic, Olympus Endoscopy, Cook Medical, Boston scientific, Erbe Medical, C2Therapeutic, Ninepoint Medical. Consultancy: Boston Scientific, Cook Medical, Covidien/Medtronic. R.E. Pouw; no disclosures. Publisher Copyright: © 2020 The Authors Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Endoscopic resection has been proven to be safe and highly effective for removing early neoplastic lesions in Barrett esophagus. It enables accurate histopathological assessment and is therefore considered as the cornerstone in the endoscopic work-up for patients with Barrett neoplasia. Various techniques are available to perform endoscopic resection. Multiband mucosectomy is the most commonly used resection technique. However, endoscopic submucosal dissection is gaining ground in the Western world. Endoscopic resection for low-risk submucosal lesions already is fully justified. Future studies have to point out whether endoscopic resection and subsequent follow-up are also justified in selected patients with high-risk submucosal tumors.
AB - Endoscopic resection has been proven to be safe and highly effective for removing early neoplastic lesions in Barrett esophagus. It enables accurate histopathological assessment and is therefore considered as the cornerstone in the endoscopic work-up for patients with Barrett neoplasia. Various techniques are available to perform endoscopic resection. Multiband mucosectomy is the most commonly used resection technique. However, endoscopic submucosal dissection is gaining ground in the Western world. Endoscopic resection for low-risk submucosal lesions already is fully justified. Future studies have to point out whether endoscopic resection and subsequent follow-up are also justified in selected patients with high-risk submucosal tumors.
KW - Barrett's esophagus
KW - Barrett's neoplasia
KW - Early esophageal adenocarcinoma
KW - Endoscopic mucosal resection
KW - Endoscopic resection
KW - Endoscopic submucosal dissection
KW - High-grade dysplasia
UR - http://www.scopus.com/inward/record.url?scp=85096164280&partnerID=8YFLogxK
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096164280&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/33213794
U2 - https://doi.org/10.1016/j.giec.2020.09.001
DO - https://doi.org/10.1016/j.giec.2020.09.001
M3 - Review article
C2 - 33213794
SN - 1052-5157
VL - 31
SP - 171
EP - 182
JO - Gastrointestinal endoscopy clinics of North America
JF - Gastrointestinal endoscopy clinics of North America
IS - 1
ER -